Drug Trial Radar · NCT07458984
FMT Capsules for rCDI
Last checked: Nov 20, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
76
Planned (sponsor's estimate)
Start
Apr 25, 2026
Primary completion
Dec 31, 2029
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Helsinki University Central HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.
Conditions
- Clostridioides Difficile Infection Recurrence
- FMT
Interventions
Healthy donor stoolBiological
Healthy donor stool given by capsules produced by the same method as in Copenhagen University Hospital
placebo capsuleBiological
Copenhagen University Hvidrovre Hospital method for capsule production
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients with recurrence of Clostridioides difficile infection (rCDI), defined as positive fecal Clostridioides difficile nucleinic acid measurement and diarrhea after Fecal Microbiota transplantation (FMT) within 12 weeks after FMT.Time frame: The investigators evaluate the number of patietns who get rCDI within 12 weeks after FMT (Placebo or active FMT).
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Helsinki University Hospital
Helsinki, Uusimaa, Finland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.